BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3465876)

  • 21. Treatment-related leukoencephalopathy. A study of three cases and literature review.
    Glass JP; Lee YY; Bruner J; Fields WS
    Medicine (Baltimore); 1986 May; 65(3):154-62. PubMed ID: 3517552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute hypokalemic tetraparesis induced by intravenous methotrexate.
    Thuss-Patience PC; Peters U; Jurkat-Rott K; Pink D; Kretzschmar A; Dörken B; Reichardt P
    J Clin Oncol; 2003 May; 21(9):1896-7. PubMed ID: 12721279
    [No Abstract]   [Full Text] [Related]  

  • 23. [High dosage methotrexate in combination with "8 in 1" in therapy of pediatric grade III/IV brain tumors].
    Schwabe D; Gussetis E; Jacobi G; Gerein V; Kornhuber B
    Klin Padiatr; 1992; 204(2):72-7. PubMed ID: 1583854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Computerized tomography in the evaluation of neurologic complications of preventive therapy of acute lymphatic leukemia].
    Bozzao L; Antonelli M; Bianco F; Colonnese C; Fantozzi LM; Floris R; Guerrisi V
    Riv Neurol; 1985; 55(2):132-8. PubMed ID: 3859905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
    J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal lobe epilepsy with hippocampal sclerosis in acute lymphoblastic leukemia.
    Kasai-Yoshida E; Ogihara M; Ozawa M; Nozaki T; Morino M; Manabe A; Hosoya R
    Pediatrics; 2013 Jul; 132(1):e252-6. PubMed ID: 23776122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
    Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroencephalographic findings in children treated with cytotoxic agents.
    Schäffler L; Imbach P; Rüdeberg A; Vassella F; Karbowski K
    Neuropsychobiology; 1984; 11(1):65-71. PubMed ID: 6738836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
    Bramwell VH; Burgers M; Sneath R; Souhami R; van Oosterom AT; Voûte PA; Rouesse J; Spooner D; Craft AW; Somers R
    J Clin Oncol; 1992 Oct; 10(10):1579-91. PubMed ID: 1403038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of brain tumors.
    Sadeh M
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938010
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
    Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
    J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
    Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
    J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.
    Gobbi PG; Broglia C; Merli F; Dell'Olio M; Stelitano C; Iannitto E; Federico M; Bertè R; Luisi D; Molica S; Cavalli C; Dezza L; Ascari E
    Cancer; 2003 Dec; 98(11):2393-401. PubMed ID: 14635074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.
    Hamamoto K; Oriuchi N; Kanazawa T; Higuchi T; Endo K
    Pediatr Neurol; 2009 Apr; 40(4):306-9. PubMed ID: 19302946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
    Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
    Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma.
    Michelagnoli MP; Lewis IJ; Gattamaneni HR; Bailey CC; Lashford LS
    Br J Cancer; 1999 Mar; 79(7-8):1174-8. PubMed ID: 10098754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.